In the
bio-tech market,
Schlumberger Limited (SLB) has been the subject of significant interest from various investment and asset management firms. Firms like
Poehling Capital Management INC,
Tidal Investments LLC,
Voloridge Investment Management LLC and
Two Sigma Advisers LP are raising their stock holdings in Schlumberger. This move indicates the growing optimism about the energy firm's performance and potential. Moreover, several Wall Street analysts are positing Schlumberger as a
top energy company with impressive upside potential.
ChampionX is a key potential acquisition for SLB, indicating the firm's dedication to growth. However, not all investor sentiment is bullish; reductions in stock positions were reported by
Janus Henderson Group PLC and
Nuveen Asset Management LLC. Additionally, critics such as
Jim Cramer have voiced concerns about its performance in the past year. Despite mixed reviews, a surge in interest from a range of investors with varying stakes signals a robust appeal in the market for Schlumberger stocks.
Schlumberger Limited SLB News Analytics from Wed, 23 Oct 2024 07:00:00 GMT to Sat, 24 May 2025 10:50:10 GMT -
Rating 8
- Innovation 3
- Information 7
- Rumor -3
